Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

September 25, 2012; 79 (13) WriteClick: Editor's Choice

Predicting Outcome after Acute Basilar Artery Occlusion Based on Admission CharacteristicsAuthor Response:

Yingkun He, Wouter J. Schonewille, Tianxio Li, Jacoba P. Greving, L.J. Kappelle, A. Algra
First published September 24, 2012, DOI: https://doi.org/10.1212/WNL.0b013e31826e1238
Yingkun He
Zhengzhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wouter J. Schonewille
Zhengzhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tianxio Li
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacoba P. Greving
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L.J. Kappelle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Algra
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Predicting Outcome after Acute Basilar Artery Occlusion Based on Admission CharacteristicsAuthor Response:
Yingkun He, Wouter J. Schonewille, Tianxio Li, Jacoba P. Greving, L.J. Kappelle, A. Algra
Neurology Sep 2012, 79 (13) 1410; DOI: 10.1212/WNL.0b013e31826e1238

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
467

Share

This article has a correction. Please see:

  • WriteClick: Editor's Choice: Predicting outcome after acute basilar artery occlusion based on admission characteristics - October 30, 2012
  • Article
  • Info & Disclosures
Loading

Editors' Note: In reference to “Predicting outcome after acute basilar artery occlusion based on admission characteristics” by Drs. Greving et al., Drs. He and Li argue against a 9-hour treatment window for intra-arterial therapy, against the use of recanalization as a predictor of outcome, and for the development of prediction models for different treatment strategies. The authors respond. Drs. Li et al. comment on the new American Academy of Neurology guideline on IV immunoglobulin (IVIg) for neuromuscular disorders, pointing out where evidence is still lacking on the use of IVIg in myasthenia gravis. Robert C. Griggs, MD, and Megan Alcauskas, MD

Greving et al.1 composed a prognostic model to predict outcome of acute basilar artery occlusion (BAO). There are some problems to be resolved before utilization.

First, according to the results of the Basilar Artery International Cooperation Study (BASICS), all 31 cases with a severe deficit and 16/22 cases with a mild to moderate deficit had a poor outcome with intra-arterial therapy (IAT) when the time to treatment exceeded 9 hours.2 Should we recommend 9 hours as the time window for treating acute BAO with IAT?

Second, the BASICS results showed recanalization protected against poor outcome in IAT and IV thrombolysis (IVT) groups.2 Recanalization is an extremely important factor but is not used as a predictor in these 3 models.1

Third, did those cases with or without occlusion and presence of prodromal minor stroke get aggressive medical therapy? If they did, aggressive medical therapy might protect more cases from stroke or occlusion and prodromal minor stroke would not only be a predictive factor but also a protective factor.3

Finally, different hospitals or centers have frequently used treatment strategies for various conditions, especially in developing countries. For these reasons, different prediction models for different treatment strategies will be necessary.

Author Response:

We appreciate the interest of Drs. He and Li and response to our prognostic article.1 We agree that recanalization is an important predictor of outcome. However, our focus was on those factors available at the time of admission.

Our prediction model is meant to be used prior to the initiation of therapy. The results from the BASICS registry showed that type of treatment had no significant influence on outcome at 1 month.2 Our data do not enable any recommendations to be made with regard to the choice between IVT vs IAT in any time window.

We agree that the design of a prediction model for different treatment strategies is a high priority, but should await the results from the recently initiated BASICS trial.4 In the meantime, we recommend treating patients with BAO with IVT. Additional IAT could be considered within a time window of 6 hours from the onset of a severe deficit. Little gain is expected in the 6- to 9-hour time window, but IAT could be considered in selected cases. The 28% good outcome rate among IA-treated patients with a mild to moderate deficit suggests there is still potential gain of IAT beyond the 9-hour time window. Primary IAT should only be considered in patients with a contraindication for IVT.

References

  1. 1.↵
    1. Greving JP,
    2. Schonewille WJ,
    3. Wijman CA,
    4. Michel P,
    5. Kappelle LJ,
    6. Algra A.
    . Predicting outcome after acute basilar artery occlusion based on admission characteristics. Neurology 2012;78:1058–1063.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Schonewille WJ,
    2. Wijman CA,
    3. Michel P,
    4. et al
    . Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol 2009;8:724–730.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Chimowitz MI,
    2. Lynn MJ,
    3. Derdeyn CP,
    4. et al
    . Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011;365:993–1003.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Basilar Artery International Cooperation Study (BASICS) trial. Available at: http://basicstrial.com/. Accessed August 11, 2012.
  • Copyright © 2012 by AAN Enterprises, Inc.
View Abstract

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • References
  • Info & Disclosures
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Related Articles

  • WriteClick: Editor's Choice: Predicting outcome after acute basilar artery occlusion based on admission characteristics
  • Spotlight on the November 20 Issue

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Five New Things
    Myasthenia gravis
    Five new things
    Jeffrey M. Statland, Emma Ciafaloni et al.
    Neurology: Clinical Practice, April 15, 2013
  • Eye on Practice
    An analysis of AAN′s evidence-based guideline for IVIg use in neurologic disorders
    Provider impact and payer perspectives
    Saty Satya-Murti, Katie M. Shepard, Joel M. Kaufman et al.
    Neurology: Clinical Practice, June 11, 2012
  • Articles
    Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals
    A. Alshekhlee, J. D. Miles, B. Katirji et al.
    Neurology, May 04, 2009
  • Special Article
    Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis
    Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
    Alexander Rae-Grant, Gregory S. Day, Ruth Ann Marrie et al.
    Neurology, April 23, 2018
Neurology: 100 (12)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise